 Lille, France; Cambridge, M A ; May 10, 2021 - GENFIT Nasdaq and Euronext: GNFT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases the Company, today announced that it published in the May 10, 2021 French legal announcements bulletin n56 Bulletin des Annonces Légales Obligatoires its convening notice that the Combined Shareholders Meeting will be held on June 15, 2021, at 2:30pm, at the Companys headquarters, located at Parc Eurasanté, 885 avenue Eugène Avinée in Loos 59120, France. 